JP2022512941A5 - - Google Patents
Info
- Publication number
- JP2022512941A5 JP2022512941A5 JP2021524356A JP2021524356A JP2022512941A5 JP 2022512941 A5 JP2022512941 A5 JP 2022512941A5 JP 2021524356 A JP2021524356 A JP 2021524356A JP 2021524356 A JP2021524356 A JP 2021524356A JP 2022512941 A5 JP2022512941 A5 JP 2022512941A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- cationic amphiphilic
- amphiphilic polymer
- nhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862758487P | 2018-11-09 | 2018-11-09 | |
| US62/758,487 | 2018-11-09 | ||
| PCT/US2019/060807 WO2020097614A2 (en) | 2018-11-09 | 2019-11-11 | Hybrid immolative cell-penetrating complexes for nucleic acid delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512941A JP2022512941A (ja) | 2022-02-07 |
| JP2022512941A5 true JP2022512941A5 (enExample) | 2022-11-17 |
Family
ID=70612292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524356A Pending JP2022512941A (ja) | 2018-11-09 | 2019-11-11 | 核酸送達のためのハイブリッド犠牲細胞透過性複合体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12215341B2 (enExample) |
| EP (1) | EP3877002A4 (enExample) |
| JP (1) | JP2022512941A (enExample) |
| KR (1) | KR20210125979A (enExample) |
| CN (1) | CN113573740A (enExample) |
| AU (1) | AU2019377137B2 (enExample) |
| CA (1) | CA3119288A1 (enExample) |
| IL (1) | IL283037A (enExample) |
| WO (1) | WO2020097614A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4185331A4 (en) * | 2020-07-24 | 2025-02-26 | The Board of Trustees of the Leland Stanford Junior University | THREE-COMPONENT VACCINE FOR COVID-19 |
| US20250177559A1 (en) | 2022-03-09 | 2025-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Branched lipid charge-altering releasable transporters for nucleic acid delivery |
| US20260103709A1 (en) | 2022-09-29 | 2026-04-16 | The Board Of Trustees Of The Leland Stanford Junior University | C-myc-targeting charge-altering releasable transporters as anti-tumor agents for breast cancer therapy |
| EP4615508A1 (en) | 2022-11-08 | 2025-09-17 | The Board Of Trustees Of The Leland Stanford Junior University | Charge-altering nucleic acid transporters with beta-amido carbonate backbones |
| WO2025034780A1 (en) * | 2023-08-08 | 2025-02-13 | The Board Of Trustees Of The Leland Stanford Junior University | Statistical charge-altering releasable transporters for nucleic acid delivery |
| WO2025034782A1 (en) * | 2023-08-08 | 2025-02-13 | The Board Of Trustees Of The Leland Stanford Junior University | Charge-altering releasable transporters from amino alcohol initiators |
| US20250302763A1 (en) * | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2026026972A1 (zh) * | 2024-08-01 | 2026-02-05 | 苏州百递博远生物科技有限公司 | 核酸递送载体及其制备与应用 |
| WO2026026974A1 (zh) * | 2024-08-01 | 2026-02-05 | 苏州百递博远生物科技有限公司 | 功能性聚碳酸酯及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5235033A (en) | 1985-03-15 | 1993-08-10 | Anti-Gene Development Group | Alpha-morpholino ribonucleoside derivatives and polymers thereof |
| JP2004535388A (ja) | 2001-04-30 | 2004-11-25 | ターゲティッド ジェネティクス コーポレイション | 脂質含有薬物送達複合体およびそれらの生成方法 |
| WO2003106636A2 (en) * | 2002-06-14 | 2003-12-24 | Mirus Corporation | Novel methods for the delivery of polynucleotides to cells |
| US9902957B2 (en) | 2011-09-06 | 2018-02-27 | The Board Of Trustees Of The Leland Stanford Junior University | Amphipathic co-oligomers for the delivery of siRNA |
| US20150329640A1 (en) * | 2012-12-20 | 2015-11-19 | Bluebird Bio, Inc. | Chimeric antigen receptors and immune cells targeting b cell malignancies |
| AU2016243583B2 (en) * | 2015-03-27 | 2022-03-10 | President And Fellows Of Harvard College | Modified T cells and methods of making and using the same |
| US10654875B2 (en) | 2015-11-12 | 2020-05-19 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery |
| CN115252807A (zh) * | 2016-07-27 | 2022-11-01 | 利兰斯坦福初级大学董事会 | 用于核酸递送的解体型细胞穿透性复合物 |
-
2019
- 2019-11-11 KR KR1020217017692A patent/KR20210125979A/ko not_active Abandoned
- 2019-11-11 US US17/292,370 patent/US12215341B2/en active Active
- 2019-11-11 CN CN201980085871.9A patent/CN113573740A/zh active Pending
- 2019-11-11 EP EP19883021.8A patent/EP3877002A4/en active Pending
- 2019-11-11 AU AU2019377137A patent/AU2019377137B2/en active Active
- 2019-11-11 CA CA3119288A patent/CA3119288A1/en active Pending
- 2019-11-11 WO PCT/US2019/060807 patent/WO2020097614A2/en not_active Ceased
- 2019-11-11 JP JP2021524356A patent/JP2022512941A/ja active Pending
-
2021
- 2021-05-09 IL IL283037A patent/IL283037A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022512941A5 (enExample) | ||
| Patel et al. | Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium | |
| AU2025220887A1 (en) | Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids | |
| EP3368687B1 (en) | Compositions and methods for targeting cancer-specific sequence variations | |
| Liu et al. | Capturing intracellular oncogenic microRNAs with self-assembled DNA nanostructures for microRNA-based cancer therapy | |
| JP5906327B2 (ja) | 磁性ナノ粒子−ＳＡＭｉＲＮＡ複合体およびその製造方法 | |
| JP2020536125A5 (enExample) | ||
| Hamilton et al. | High-throughput in vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route | |
| JP2023511271A (ja) | 核酸搭載細胞外小胞 | |
| Wang et al. | Gadolinium embedded iron oxide nanoclusters as T 1–T 2 dual-modal MRI-visible vectors for safe and efficient siRNA delivery | |
| CN102971002A (zh) | 核酸递送用组合物及载体组合物、使用其的药物组合物以及核酸递送方法 | |
| CN104244987A (zh) | 新型寡核苷酸缀合物及其应用 | |
| JP2007525958A5 (enExample) | ||
| AU2022201755B2 (en) | Pharmaceutical composition for preventing or treating liver cancer | |
| CN112512595A (zh) | 心脏、骨骼肌和肌肉干细胞中的体内同源性定向修复 | |
| US11564884B2 (en) | Cationic block polymer micelles for delivery of biological agents | |
| JP2007525958A (ja) | アデノウイルスのポリマーカプセル化 | |
| US20160159834A1 (en) | Alkyne phosphoramidites and preparation of spherical nucleic acid constructs | |
| Wu et al. | Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models | |
| Mullick Chowdhury et al. | Graphene nanoribbon-based platform for highly efficacious nuclear gene delivery | |
| Cao et al. | Gene delivery by a cationic and thermosensitive nanogel promoted established tumor growth inhibition | |
| US20220307028A1 (en) | Compositions and methods for mitigation of ischemic reperfusion injury | |
| JP2009527505A5 (enExample) | ||
| WO2024140546A1 (zh) | 一种阳离子脂质化合物及制备方法和应用、mRNA递送系统 | |
| CN118079010A (zh) | 靶向脾脏的聚合物-脂质组合物、核酸递送纳米颗粒及其制备方法和应用 |